Breakout Re-testingCPHL
Closed at 98.40 (16-09-2025)
Breakout Re-testing around 95 - 98
Sustaining this level may lead it
towards 105 - 110 once again.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.64 PKR
833.46 M PKR
12.41 B PKR
108.47 M
About Citi Pharma Ltd.
Sector
Industry
CEO
Rizwan Ahmad
Website
Headquarters
Lahore
Founded
2012
ISIN
PK0126201018
FIGI
BBG011LQGDH1
Citi Pharma Ltd. engages in the manufacturing and sale of pharmaceuticals, medical chemicals, and botanical products. Its products portfolio includes paracetamol, Penicillin/Amoxicillin, Levofloxacin, Cefixime/Cephalosporin, Ciprofloxacin, Cephradine, Norfloxacin, Aspirin, Ibuprofen, and Ascorbic Acid. The company was founded on October 8, 2012 and is headquartered in Lahore, Pakistan.
Related stocks
Bullish on All time frames.CPHL Analysis
CMO 93.98 (02-09-2025 02:50PM)
Bullish on All time frames.
Near Important Resistance 95 - 98.
Crossing & Sustaining this level may lead it
towards 105 - 110.
Upside targets (if 110 is Crossed iwth Huge Volumes)
can be around 140 - 150.
On the flip side, 93 & then 83 are 2 Important
Su
CITI PHARMA - PSX2nd Breakout attempt of Diagnol Resistance Trendline got rejected.
Rejection Zone is also an inverter Fair Value Gap from the last Sell.
Bearish Divergence is Flashing on Chaikin Money Flow indicator.
Formed a Bearish Spinning Top Candle on the 4 hour chart. With 20m Distribution Volume. Which i
CPHL just broke its downtrend and about to start UP trend CPHL just broke its downtrend and about to start UP trend. Short entry can be taken and after that the the new targets can be set.
Entry : 95
SL : 80
TP2 : 100
TP2 : 110
CPHL Analysis-Long Trade13/4/27
TF- 1D
CPHL has recently completed its correction and started a new bullish trend from Rs 82.
Buying at current level is not recommended
Buy after RT of recent BO 88-92
TP1 109
TP2 116
TP3 126
SL 78
#CPHL is above green sky (strong bullish zone )#CPHL is now above green sky (Strong bullish zone). It is expected to cross 110 and 130 level.
Note: This is not a buy or sell call, trade at your own will. Use stop loss as per your strategy.
CPHL Stock Trading Strategy:CPHL has posted a breakout and is currently trading at 98. The strategy is to buy around 98-94, set a stop loss at 90, and target a price of 108.
CPHL Buying setupHere is the corrected text:
"CpHL is currently trading in the buying zone. We can buy:
1. Around 87-83
2. Second buy when price crosses or closes above 93
Stop Loss: 81
Target: 108
Further hold if closes above 108."
CPHL BUYING SETUPHere is the corrected text:
"CpHL is currently trading in the buying zone. We can buy:
1. Around 87-83
2. Second buy when price crosses or closes above 93
Stop Loss: 81
Target: 108
Further hold if closes above 108."
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CPHL is 96.31 PKR — it has decreased by −0.59% in the past 24 hours. Watch Citi Pharma Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on PSX exchange Citi Pharma Ltd. stocks are traded under the ticker CPHL.
CPHL stock has fallen by −0.71% compared to the previous week, the month change is a 0.85% rise, over the last year Citi Pharma Ltd. has showed a 175.25% increase.
CPHL reached its all-time high on Feb 11, 2025 with the price of 109.30 PKR, and its all-time low was 19.07 PKR and was reached on Sep 1, 2023. View more price dynamics on CPHL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CPHL stock is 1.77% volatile and has beta coefficient of 2.01. Track Citi Pharma Ltd. stock price on the chart and check out the list of the most volatile stocks — is Citi Pharma Ltd. there?
Yes, you can track Citi Pharma Ltd. financials in yearly and quarterly reports right on TradingView.
Citi Pharma Ltd. is going to release the next earnings report on Dec 3, 2025. Keep track of upcoming events with our Earnings Calendar.
CPHL net income for the last quarter is 220.38 M PKR, while the quarter before that showed 256.98 M PKR of net income which accounts for −14.24% change. Track more Citi Pharma Ltd. financial stats to get the full picture.
Yes, CPHL dividends are paid annually. The last dividend per share was 3.25 PKR. As of today, Dividend Yield (TTM)% is 3.35%. Tracking Citi Pharma Ltd. dividends might help you take more informed decisions.
Citi Pharma Ltd. dividend yield was 11.40% in 2024, and payout ratio reached 89.09%. The year before the numbers were 11.72% and 86.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 22, 2025, the company has 615 employees. See our rating of the largest employees — is Citi Pharma Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Citi Pharma Ltd. EBITDA is 1.46 B PKR, and current EBITDA margin is 9.94%. See more stats in Citi Pharma Ltd. financial statements.
Like other stocks, CPHL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Citi Pharma Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Citi Pharma Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Citi Pharma Ltd. stock shows the strong buy signal. See more of Citi Pharma Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.